Rayson, D., Bertin, J., Lemelin, M., Tong, M., Ng, R., Ding, P., . . . Lupichuk, S. (2026). Real-World Utilization of Palbociclib as First-Line Treatment for Canadian HR+/HER2− Women with Metastatic Breast Cancer: Results from PALCAN Study. Current Oncology, 31(2), 81-93.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Rayson, Daniel, et al. "Real-World Utilization of Palbociclib as First-Line Treatment for Canadian HR+/HER2− Women with Metastatic Breast Cancer: Results from PALCAN Study."
Current Oncology 31, no. 2 (2026): 81-93.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Rayson, Daniel, et al. "Real-World Utilization of Palbociclib as First-Line Treatment for Canadian HR+/HER2− Women with Metastatic Breast Cancer: Results from PALCAN Study."
Current Oncology, vol. 31, no. 2, 2026, pp. 81-93.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.